AIM: To determine hepatitis C virus (HCV) seroprevalence and its genotypes, and to identify the factors associated with HCV infection. METHODS: This cross-sectional study, conducted in two prisons (one male and one female) in the State of Sergipe, Brazil, comprised 422 subjects. All of the prisoners underwent a rapid test for the detection of HCV antibodies. Patients with a positive result were tested for anti-HCV by enzyme linked immunosorbent assay and for HCV RNA by qualitative polymerase chain reaction (PCR). The virus genotype was defined in every serum sample that presented positive for PCR-HCV. In order to determine the factors independently associated with positive serology for HCV, multivariate logistic regression was used. RESULTS: HCV seroprevalence was 3.1%. Of the 13 subjects with positive anti-HCV, 11 had viremia confirmed by PCR. Of these, 90.9% had genotype 1. A total of 43 (10.2%) were injecting drug users, and HCV seroprevalence in this subgroup was 20.6%. The variable most strongly associated with positive serology for HCV was use of injecting drugs [odds ratio (OR), 23.3; 95% confidence interval (CI), 6.0-90.8]. Age over 30 years (OR, 5.5; 95%CI, 1.1-29.2), history of syphilis (OR, 9.8; 95%CI, 1.7-55.2) and history of household contact with HCV positive individual (OR, 14.1; 95%CI, 2.3-85.4) were also independently associated with HCV infection. CONCLUSION: Most of the HCV transmissions result from parenteral exposure. However, there is evidence to suggest a role for sex and household contact with an infected subject in virus transmission.
AIM: To determine hepatitis C virus (HCV) seroprevalence and its genotypes, and to identify the factors associated with HCV infection. METHODS: This cross-sectional study, conducted in two prisons (one male and one female) in the State of Sergipe, Brazil, comprised 422 subjects. All of the prisoners underwent a rapid test for the detection of HCV antibodies. Patients with a positive result were tested for anti-HCV by enzyme linked immunosorbent assay and for HCV RNA by qualitative polymerase chain reaction (PCR). The virus genotype was defined in every serum sample that presented positive for PCR-HCV. In order to determine the factors independently associated with positive serology for HCV, multivariate logistic regression was used. RESULTS:HCV seroprevalence was 3.1%. Of the 13 subjects with positive anti-HCV, 11 had viremia confirmed by PCR. Of these, 90.9% had genotype 1. A total of 43 (10.2%) were injecting drug users, and HCV seroprevalence in this subgroup was 20.6%. The variable most strongly associated with positive serology for HCV was use of injecting drugs [odds ratio (OR), 23.3; 95% confidence interval (CI), 6.0-90.8]. Age over 30 years (OR, 5.5; 95%CI, 1.1-29.2), history of syphilis (OR, 9.8; 95%CI, 1.7-55.2) and history of household contact with HCV positive individual (OR, 14.1; 95%CI, 2.3-85.4) were also independently associated with HCV infection. CONCLUSION: Most of the HCV transmissions result from parenteral exposure. However, there is evidence to suggest a role for sex and household contact with an infected subject in virus transmission.
Entities:
Keywords:
Brazil; Cross sectional analysis; Drug abusers; Hepatitis C; Prisoners
Authors: Carlos Perone; Dora Mendez Del Castillo; Gilsimary Lessa Pereira; Nara de Oliveira Carvalho; José Nélio Januário; Rosângela Teixeira Journal: Rev Soc Bras Med Trop Date: 2008 May-Jun Impact factor: 1.581
Authors: S Campiotto; J R R Pinho; F J Carrilho; L C Da Silva; F J D Souto; V Spinelli; L M M B Pereira; H S M Coelho; A O Silva; J C Fonseca; H Rosa; C M C Lacet; A P Bernardini Journal: Braz J Med Biol Res Date: 2005-01-18 Impact factor: 2.590
Authors: Rena K Fox; Sue L Currie; Jennifer Evans; Teresa L Wright; Leslie Tobler; Bruce Phelps; Michael P Busch; Kimberly A Page-Shafer Journal: Clin Infect Dis Date: 2005-06-09 Impact factor: 9.079
Authors: Andrew A Adjei; Henry B Armah; Foster Gbagbo; William K Ampofo; Isaac K E Quaye; Ian F A Hesse; George Mensah Journal: J Med Microbiol Date: 2007-03 Impact factor: 2.472
Authors: Belinda G O'Sullivan; Michael H Levy; Kate A Dolan; Jeffrey J Post; Sharon G Barton; Dominic E Dwyer; John M Kaldor; Andrew E Grulich Journal: Med J Aust Date: 2003-06-02 Impact factor: 7.738
Authors: Harnoldo Colares Coelho; Sabrina Alberti Nóbrega de Oliveira; Juliana Custódio Miguel; Maria de Lourdes Aguiar Oliveira; José Fernando de Castro Figueiredo; Gleici Castro Perdoná; Afonso Dinis Costa Passos Journal: Rev Soc Bras Med Trop Date: 2009 Jul-Aug Impact factor: 1.581
Authors: Monica Alonso; Annika Gutzman; Rafael Mazin; Carlos E Pinzon; Ludovic Reveiz; Massimo Ghidinelli Journal: Int J Public Health Date: 2015-08-23 Impact factor: 3.380